144 related articles for article (PubMed ID: 31150396)
1. Correlates of HIV detection among breastfeeding postpartum Kenyan women eligible under Option B.
Chan M; Muriuki EM; Emery S; Kanthula R; Chohan V; Frenkel LM; Wald A; Chohan B; Overbaugh J; Roxby AC
PLoS One; 2019; 14(5):e0216252. PubMed ID: 31150396
[TBL] [Abstract][Full Text] [Related]
2. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
3. Virologic and immunologic failure, drug resistance and mortality during the first 24 months postpartum among HIV-infected women initiated on antiretroviral therapy for life in the Mitra plus Study, Dar es Salaam, Tanzania.
Ngarina M; Kilewo C; Karlsson K; Aboud S; Karlsson A; Marrone G; Leyna G; Ekström AM; Biberfeld G
BMC Infect Dis; 2015 Apr; 15():175. PubMed ID: 25886277
[TBL] [Abstract][Full Text] [Related]
4. Integration of postpartum healthcare services for HIV-infected women and their infants in South Africa: A randomised controlled trial.
Myer L; Phillips TK; Zerbe A; Brittain K; Lesosky M; Hsiao NY; Remien RH; Mellins CA; McIntyre JA; Abrams EJ
PLoS Med; 2018 Mar; 15(3):e1002547. PubMed ID: 29601570
[TBL] [Abstract][Full Text] [Related]
5. Food insecurity, drug resistance and non-disclosure are associated with virologic non-suppression among HIV pregnant women on antiretroviral treatment.
Chohan BH; Ronen K; Khasimwa B; Matemo D; Osborn L; Unger JA; Drake AL; Beck IA; Frenkel LM; Kinuthia J; John-Stewart G
PLoS One; 2021; 16(8):e0256249. PubMed ID: 34407133
[TBL] [Abstract][Full Text] [Related]
6. Hair concentrations of antiretrovirals predict viral suppression in HIV-infected pregnant and breastfeeding Ugandan women.
Koss CA; Natureeba P; Mwesigwa J; Cohan D; Nzarubara B; Bacchetti P; Horng H; Clark TD; Plenty A; Ruel TD; Achan J; Charlebois ED; Kamya MR; Havlir DV; Gandhi M
AIDS; 2015 Apr; 29(7):825-30. PubMed ID: 25985404
[TBL] [Abstract][Full Text] [Related]
7. Frequency of Viremic Episodes in HIV-Infected Women Initiating Antiretroviral Therapy During Pregnancy: A Cohort Study.
Myer L; Dunning L; Lesosky M; Hsiao NY; Phillips T; Petro G; Zerbe A; McIntyre JA; Abrams EJ
Clin Infect Dis; 2017 Feb; 64(4):422-427. PubMed ID: 27927852
[TBL] [Abstract][Full Text] [Related]
8. Viral Suppression and Retention in Care up to 5 Years After Initiation of Lifelong ART During Pregnancy (Option B+) in Rural Uganda.
Koss CA; Natureeba P; Kwarisiima D; Ogena M; Clark TD; Olwoch P; Cohan D; Okiring J; Charlebois ED; Kamya MR; Havlir DV
J Acquir Immune Defic Syndr; 2017 Mar; 74(3):279-284. PubMed ID: 27828878
[TBL] [Abstract][Full Text] [Related]
9. HIV virologic failure and its predictors among HIV-infected adults on antiretroviral therapy in the African Cohort Study.
Kiweewa F; Esber A; Musingye E; Reed D; Crowell TA; Cham F; Semwogerere M; Namagembe R; Nambuya A; Kafeero C; Tindikahwa A; Eller LA; Millard M; Gelderblom HC; Keshinro B; Adamu Y; Maswai J; Owuoth J; Sing'oei VC; Maganga L; Bahemana E; Khamadi S; Robb ML; Ake JA; Polyak CS; Kibuuka H
PLoS One; 2019; 14(2):e0211344. PubMed ID: 30721233
[TBL] [Abstract][Full Text] [Related]
10. HIV viraemia and mother-to-child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa.
Myer L; Phillips TK; McIntyre JA; Hsiao NY; Petro G; Zerbe A; Ramjith J; Bekker LG; Abrams EJ
HIV Med; 2017 Feb; 18(2):80-88. PubMed ID: 27353189
[TBL] [Abstract][Full Text] [Related]
11. HIV-infected women on antiretroviral treatment have increased mortality during pregnant and postpartum periods.
Matthews LT; Kaida A; Kanters S; Byakwagamd H; Mocello AR; Muzoora C; Kembabazi A; Haberer JE; Martin JN; Bangsberg DR; Hunt PW
AIDS; 2013 Oct; 27 Suppl 1(0 1):S105-12. PubMed ID: 24088676
[TBL] [Abstract][Full Text] [Related]
12. Dynamic Changes in Breast Milk Microbiome in the Early Postpartum Period of Kenyan Women Living with HIV Are Influenced by Antibiotics but Not Antiretrovirals.
Maqsood R; Skidmore PT; Holland LA; Au JL; Khan AK; Wu LI; Ma N; Begnel ER; Chohan BH; Adhiambo J; John-Stewart G; Kiarie J; Kinuthia J; Chung MH; Richardson BA; Slyker J; Lehman DA; Lim ES
Microbiol Spectr; 2022 Apr; 10(2):e0208021. PubMed ID: 35384692
[TBL] [Abstract][Full Text] [Related]
13. Retention and viral suppression of newly diagnosed and known HIV positive pregnant women on Option B+ in Western Kenya.
Akama E; Nimz A; Blat C; Moghadassi M; Oyaro P; Maloba M; Cohen CR; Bukusi EA; Abuogi LL
AIDS Care; 2019 Mar; 31(3):333-339. PubMed ID: 30261742
[TBL] [Abstract][Full Text] [Related]
14. Detectable Viral Load in Late Pregnancy among Women in the Rwanda Option B+ PMTCT Program: Enrollment Results from the Kabeho Study.
Gill MM; Hoffman HJ; Bobrow EA; Mugwaneza P; Ndatimana D; Ndayisaba GF; Baribwira C; Guay L; Asiimwe A
PLoS One; 2016; 11(12):e0168671. PubMed ID: 28006001
[TBL] [Abstract][Full Text] [Related]
15. Impact of universal antiretroviral therapy for pregnant and postpartum women on antiretroviral therapy uptake and retention.
Abrams EJ; Langwenya N; Gachuhi A; Zerbe A; Nuwagaba-Biribonwoha H; Mthethwa-Hleta S; Sahabo R; Lesosky M; Okello V; Myer L
AIDS; 2019 Jan; 33(1):45-54. PubMed ID: 30289804
[TBL] [Abstract][Full Text] [Related]
16. Impact of point-of-care HIV viral load and targeted drug resistance mutation testing on viral suppression among Kenyan pregnant and postpartum women: results from a prospective cohort study (Opt4Mamas).
Patel RC; Oyaro P; Thomas KK; Basha GW; Wagude J; Mukui I; Brown E; Hassan SA; Kinywa E; Oluoch F; Odhiambo F; Oyaro B; Kingwara L; Karauki E; Yongo N; Otieno L; John-Stewart GC; Abuogi LL
J Int AIDS Soc; 2023 Nov; 26(11):e26182. PubMed ID: 37938856
[TBL] [Abstract][Full Text] [Related]
17. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
[TBL] [Abstract][Full Text] [Related]
18. Population-level viral suppression among pregnant and postpartum women in a universal test and treat trial.
Kabami J; Balzer LB; Saddiki H; Ayieko J; Kwarisiima D; Atukunda M; Charlebois ED; Clark TD; Koss CA; Ruel T; Bukusi EA; Cohen CR; Musoke P; Petersen ML; Havlir DV; Kamya MR; Chamie G
AIDS; 2020 Jul; 34(9):1407-1415. PubMed ID: 32472768
[TBL] [Abstract][Full Text] [Related]
19. Using a composite adherence tool to assess ART response and risk factors of poor adherence in pregnant and breastfeeding HIV-positive Cameroonian women at 6 and 12 months after initiating option B.
Atanga PN; Ndetan HT; Fon PN; Meriki HD; Muffih TP; Achidi EA; Hoelscher M; Kroidl A
BMC Pregnancy Childbirth; 2018 Oct; 18(1):418. PubMed ID: 30359239
[TBL] [Abstract][Full Text] [Related]
20. Younger Age Predicts Failure to Achieve Viral Suppression and Virologic Rebound Among HIV-1-Infected Persons in Serodiscordant Partnerships.
Mujugira A; Celum C; Tappero JW; Ronald A; Mugo N; Baeten JM
AIDS Res Hum Retroviruses; 2016 Feb; 32(2):148-54. PubMed ID: 26670218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
